MarketResearch.biz delivers in-depth insights on the global peptide therapeutics market in its upcoming report titled, “Global Peptide Therapeutics Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global peptide therapeutics market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global peptide therapeutics market report has been segmented on the basis of type, technology, application, route of administration, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analysed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Peptides represent a unique class of pharmaceutical compounds, it is recognized for being efficacious and selective. Demand for peptides in clinical therapeutics is expected to increase as peptides have low production complexity as compared to that of protein based biopharmaceuticals, which thereby reduces overall production cost.
Increasing incidence of cancer is expected to support the growth of the global peptide therapeutics market over the forecast period. According to American Cancer Society, 1.6 million new cancer cases and 600,920 cancer deaths have been projected to occur in the US in 2017. It also stated that the cancer incidence rate is 20% higher in men than in women. Increasing number of cases of metabolic disorder is other factor expected to boost growth of the target market over the forecast period.
However, stringent government regulation for the approval process is major factor expected to restraint the growth of the global peptide therapeutics market over the forecast period.
Based on type, the global peptide therapeutics market is segmented based on branded peptide and generic peptide. The branded peptide segment is expected to account major revenue share. Continuous focus by manufacturers operating in the market to develop innovative and novel peptide therapeutics products is expected to drive the growth of the branded peptide segment over the forecast period.
North America market dominates the global peptide therapeutics market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to presence of well-developed healthcare infrastructure as well as presence of significant market players in the region. Europe accounts for second-largest revenue share contribution to the global peptide therapeutics market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to the developing healthcare infrastructure and increasing funding for research and development by the players operating in the region.
Global peptide therapeutics market segmentation, by type:
- Branded Peptide
- Generic Peptide
Global peptide therapeutics market segmentation, by technology:
- Solid Phase Peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Hybrid Technology
Global peptide therapeutics market segmentation, by application:
- Metabolic Disease
- Respiratory Disease
- Cardiovascular Disease
- Infectious Disease
Global peptide therapeutics market segmentation, by route of administration:
- Oral Administration
- Parenteral Administration
- Others (Pulmonary and Mucosal)
Global peptide therapeutics market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Bachem Holding AG
- Eli Lilly and Company
- Pfizer Inc.
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- Lonza Inc.
- Sanofi S.A.
- Bristol-Myers Squibb(BMS)
- AstraZeneca PLC
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!